OverviewSuggest Edit

AtriCure provides atrial fibrillation solutions to medical centers. The Company offers innovative solutions for ablation, such as Isolator Synergy and Isolator Synergy Access clamps, COBRA Fusion surgical ablation system and EPi-Sense guided coagulation system. It also provides SUBTLE cannula, multifunctional pens and linear ablation devices. In addition, the Company offers cryoICE cryoablation system, AtriClip system, Lumitip dissector and Estech cardiac surgery instruments.
TypePublic
Founded2000
HQMason, OH, US
Websiteatricure.com
Employee Ratings4.4

Latest Updates

Employees (est.) (Jan 2020)730(+18%)
Job Openings34
Revenue (FY, 2020)$206.5 M(-10%)
Share Price (Jun 2021)$74.8
Cybersecurity ratingBMore

Key People/Management at AtriCure

Michael H. Carrel

Michael H. Carrel

President and Chief Executive Officer
Douglas Seith

Douglas Seith

COO
Justin Noznesky

Justin Noznesky

Chief Marketing and Strategy Officer
Angela L. Wirick

Angela L. Wirick

Chief Financial Officer
Tonya Austin

Tonya Austin

Chief Human Resources Officer
Douglas J. Seith

Douglas J. Seith

Chief Operating Officer
Show more

AtriCure Office Locations

AtriCure has offices in Mason, Albany, Allen, Allentown and in 20 other locations
Mason, OH, US (HQ)
7555 Innovation Way
Albany, NY, US
Albany, NY, USA
Allen, TX, US
Allen, TX, USA
Allentown, PA, US
Allentown, PA, USA
Boston, MA, US
Boston, MA, USA
Chicago, IL, US
Chicago, IL, USA
Show all (25)

AtriCure Financials and Metrics

AtriCure Revenue

Embed Graph
View revenue for all periods
AtriCure's revenue was reported to be $206.53 m in FY, 2020
USD

Revenue (FY, 2020)

206.5m

Gross profit (FY, 2020)

205.9m

Gross profit margin (FY, 2020), %

99.7%

Net income (FY, 2020)

(48.2m)

EBIT (FY, 2020)

(44.2m)

Market capitalization (7-Jun-2021)

3.4b

Closing stock price (7-Jun-2021)

74.8

Cash (31-Dec-2020)

41.9m

EV

3.4b
AtriCure's current market capitalization is $3.4 b.
USDQ2, 2011

Financial Leverage

2.1 x
Show all financial metrics

AtriCure Acquisitions / Subsidiaries

Company NameDateDeal Size
SentreHEARTAugust 15, 2019$300 m

AtriCure Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

AtriCure Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

AtriCure Online and Social Media Presence

Embed Graph

AtriCure News and Updates

$ 156.6 Million Growth in Global Endovenous Ablation Devices Market During 2021-2025 | Featuring Key Vendors Including AngioDynamics Inc., AtriCure Inc., and Eufoton srl | Technavio

NEW YORK, Feb. 22, 2021 /PRNewswire/ -- Tavio announces the release of its latest report on the endovenous ablation devices market. The market is segmented by product (EVLT devices, RFA devices, and NTNT devices) and geography (North America, Europe, Asia, and ROW). Get a Free Sample...

Ablation Technologies Market Size, Growth rate, Market Statistics and Future Forecasts to 2023

The report depicts the global and regional total market of Ablation Technologies industry including capacity, production, production value, cost/profit, supply/demand and import/export details. Posted via Industry Today. Follow us on Twitter @IndustryToday

New Research Report On Epicardial LAA Closure Device Market Analysis, Market Size, Regional Outlook, Competitive Strategies and Forecasts, to 2021, Focusing on Top Key Vendors like AtriCure, Boston Scientific, St. Jude, Coherex Medical, Lifetech Scientifi

Epicardial LAA (Left Atrial Appendage) Closure Device Market by Product (Epicardial LAA Closure Device and Endocardial LAA Closure Device) and End User (Hospitals, Ambulatory Surgical Centers, and Heart Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2021Top Companies Profiled in …

Left Atrial Appendage (LAA) Closure Devices Market to Make Great Impact in Near Future by 2025

The North America is dominating and contributed the leading shares to the global left atrial appendage (LAA) closure devices market in terms of revenue and expected to register a significant growth during forecast period. Posted via Industry Today. Follow us on Twitter @IndustryToday

AtriCure Blogs

Angela L. Wirick

Angela L. Wirick, CPA Chief Financial Officer Angela L. Wirick, C.P.A. was appointed Chief Financial Officer in August 2020. Immediately prior to this, Ms. Wirick served as AtriCure’s Vice President, Finance for four years, where she led the global accounting and finance functions of the company a…

Privacy Policy for California Residents

Privacy Policy for California Residents This Privacy Notice for California Residents supplements the information contained in AtriCure's Privacy Policy which can be found on the internet at https://www.atricure.com/privacy-notice and applies solely to all employees, visitors, users, and others who…

AtriCure could pay up to $300M to acquire California firm

[ AtriCure, Inc. ]Mason-based medical device maker AtriCure expects to close the deal in the next few days.Reference Source

AtriCure Enters Into Definitive Agreement to Acquire SentreHEART | AtriCure, Inc.

[ AtriCure, Inc. ]The Investor Relations website contains information about AtriCure, Inc.'s business for stockholders, potential investors, and financial analysts.Reference Source

ACT against Afib

[ AtriCure, Inc. ]Jack, a coronary artery bypass patient with concomitant surgical ablation (SA), and his wife share their story and why they are happy he received SA with his quadruple bypass. His surgeon, Dr. Gregory, also shares his perspective on how technology has advanced and why he’s passiona…

Help for hearts - American entity provides free surgery for 10 Jamaicans

[ AtriCure, Inc. ]Kerrian Clarke-Wilson and Vanessa Rowe are breathing easier today having benefited from surgeries to treat the potentially fatal rheumatiReference Source
Show more

AtriCure Frequently Asked Questions

  • When was AtriCure founded?

    AtriCure was founded in 2000.

  • Who are AtriCure key executives?

    AtriCure's key executives are Michael H. Carrel, Douglas Seith and Justin Noznesky.

  • How many employees does AtriCure have?

    AtriCure has 730 employees.

  • What is AtriCure revenue?

    Latest AtriCure annual revenue is $206.5 m.

  • What is AtriCure revenue per employee?

    Latest AtriCure revenue per employee is $282.9 k.

  • Who are AtriCure competitors?

    Competitors of AtriCure include Mammotome, ClaroNav and GATT Technologies.

  • Where is AtriCure headquarters?

    AtriCure headquarters is located at 7555 Innovation Way, Mason.

  • Where are AtriCure offices?

    AtriCure has offices in Mason, Albany, Allen, Allentown and in 20 other locations.

  • How many offices does AtriCure have?

    AtriCure has 25 offices.